This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Supravalvular aortic stenosis (aortic stenosis) Supravalvular Aortic Stenosis


1. History

Supravalvular aortic stenosis (SVAS) was first systematically described in 1961 when Williams et al. reported a syndrome characterized by unusual elfin facies, hypercalcemia, mental retardation and aortic stenosis. In the same year Beuren et al. also described a similar group of cases, and this syndrome is known today as Williams-Beuren syndrome (WBS).

The genetic basis was revealed in 1993–1994. A microdeletion of about 1.5–1.8 Mb at chromosome 7q11.23 including the elastin (ELN) gene was identified as the cause of WBS. It was subsequently shown that isolated SVAS (nonsyndromic) arises from a point mutation or isolated deletion of the ELN gene.

Surgical treatment developed after McGoon and Edwards performed the first successful corrective operation in 1961. Various enlargement aortoplasties (patch aortoplasty, three-patch technique, pantaloon patch, etc.) were developed, and surgical results steadily improved. Early surgery is now established as the standard treatment, and evaluation for coexisting coronary stenosis is an essential preoperative step.

2. Causes

The main cause of SVAS is an abnormality of the elastin (ELN) gene. Elastin is a protein essential for forming the elastic fibers of the aortic wall and plays a key role in maintaining vascular elasticity and structural integrity.

Syndromic SVAS (Williams-Beuren syndrome): Caused by a microdeletion of about 1.5–1.8 Mb at chromosome 7q11.23, in which about 25–28 genes including the ELN gene are deleted simultaneously. This causes haploinsufficiency, reducing elastin protein production.

Isolated SVAS (nonsyndromic): Caused by point mutations (missense, nonsense, splice site) or small insertions/deletions of the ELN gene. It shows an autosomal dominant inheritance pattern, and familial occurrence is possible.

Because of elastin haploinsufficiency, formation of elastic fibers in the aortic wall decreases, and compensatory proliferation of smooth muscle cells and collagen deposition increase. As a result, a thickened fibromuscular ring forms in the ascending aorta (mainly the supravalvular ridge, just above the sinotubular junction), causing stenosis.

Because the coronary ostia lie distal (inside) to the stenosis, coronary perfusion is exposed to high pressure, and as the stenosis progresses the coronary ostia themselves may also become stenotic, so the risk of ischemia is high.

3. Genetics

The genetics of SVAS is divided into syndromic and nonsyndromic:

Williams-Beuren syndrome (WBS):

Nonsyndromic isolated SVAS:

Diagnosis is made by confirming the 7q11.23 deletion with FISH, chromosomal microarray (CMA) or MLPA, or by confirming point mutations with ELN gene sequencing. When WBS is suspected, CMA is recommended as the first-line test.

4. General epidemiology

SVAS is the rarest form of congenital aortic stenosis, accounting for about 5–8% of all congenital aortic stenosis. It is much rarer than valvular aortic stenosis (~75%) and subvalvular stenosis (~20%).

The incidence of WBS is reported as 1 in 7,500–20,000, and in Korea several dozen cases are diagnosed per year. Cardiovascular abnormalities accompany about 70–80% of WBS patients, and among them SVAS is the most common (~80%). Peripheral pulmonary artery stenosis is also commonly associated (~75%).

Isolated (nonsyndromic) SVAS is very rare, and accurate incidence statistics are lacking. Familial cases present with a completely different clinical picture (no intellectual disability, no distinctive facies), so differential diagnosis is necessary.

As for sex distribution, WBS itself is equal in men and women, and there is no marked sex difference in isolated SVAS either. It can be registered under Special Copayment Reduction V272 in Korea and is eligible for rare disease support.

5. Pathophysiology

The pathogenesis of SVAS begins with haploinsufficiency of the elastin protein. The normal aortic wall has a repeating structure of elastic lamellae in the media, with smooth muscle cells arranged between the lamellae. When elastin synthesis decreases, the following process occurs in a cascade:

  1. Decreased number of elastic lamellae and abnormal elastin fiber formation
  2. Compensatory proliferation and migration of smooth muscle cells
  3. Excessive collagen deposition increases vessel wall stiffness
  4. Increased medial thickness → luminal narrowing

The stenosis mainly takes the form of thickening of the aortic valve ridge at the level of the aortic valve commissures, and is most common at the sinotubular junction above the sinus of Valsalva. In severe cases, diffuse lesions may appear involving the entire aorta or even the pulmonary artery branches (diffuse SVAS).

Abnormal coronary perfusion: Because the coronary ostia lie distal (medial) to the stenosis, they are exposed to high-pressure blood flow during systole. This causes early fibrosis and stenosis of the coronary artery wall and is a cause of myocardial ischemia and sudden death. Both the left and right coronary ostia may become stenotic, which is clinically very dangerous.

6. Symptoms

The symptoms of SVAS vary according to the degree of stenosis, coronary involvement and the presence of WBS.

Cardiovascular symptoms:

Non-cardiovascular symptoms associated with WBS:

7. Signs

Physical examination findings in SVAS patients:

Cardiovascular findings:

WBS-specific facial findings (elfin facies):

Other findings: Joint hyperlaxity, low muscle tone, short stature.

8. Screening

Screening for SVAS and WBS:

Clinical screening:

Genetic screening:

Prenatal screening:

Family screening: When isolated SVAS is diagnosed, perform cardiac and genetic testing of first-degree relatives.

9. Diagnosis

The diagnosis of SVAS uses clinical evaluation, echocardiography, imaging studies and genetic testing in combination.

Echocardiography:

Cardiovascular CT angiography (CTA) and cardiac MRI:

Cardiac catheterization and coronary angiography:

Genetic testing:

Exercise stress test: Useful for evaluating the degree of stenosis, exercise-induced symptoms and blood pressure response, but caution is required when coronary stenosis is present.

10. Treatment

Treatment of SVAS is determined by the degree of stenosis and coronary involvement.

Indications for surgery:

Surgical methods:

Intervention for peripheral pulmonary artery stenosis: Balloon dilation or stent placement. For distal pulmonary artery branches where surgical intervention is difficult, interventional procedures are the main treatment option.

WBS multidisciplinary care:

11. Prognosis

The surgical prognosis of SVAS depends greatly on whether the coronary arteries are involved.

Surgical results:

Problems in long-term follow-up:

Prognosis of WBS in adults:

12. Prevention

Prevention of SVAS focuses on early detection and prevention of sudden death rather than prevention of occurrence.

Genetic counseling and family screening:

Prevention of sudden death:

Regular follow-up:

13. References

  1. Williams JC, Barratt-Boyes BG, Lowe JB. Supravalvular aortic stenosis. Circulation. 1961;24:1311-1318. DOI:10.1161/01.CIR.24.6.1311
  2. Ewart AK, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet. 1993;5(1):11-16. PMID:8220421
  3. Stamm C, et al. Surgical treatment of supravalvular aortic stenosis: do we need more than one patch? J Thorac Cardiovasc Surg. 1999;118(2):252-261. PMID:10423997
  4. Wessel A, et al. Long-term follow-up in supravalvular aortic stenosis. Eur J Pediatr. 1994;153(11):871-876. PMID:7843227
  5. Collins RT 2nd, et al. Cardiovascular disease in Williams syndrome. Circulation. 2013;127(21):2125-2134. PMID:23690465
  6. Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239-252. PMID:20089974
  7. Kruzliak P, et al. Supravalvular aortic stenosis: 36 years of surgical experience with different techniques of repair. Heart Surg Forum. 2013;16(5):E283-288. PMID:24163071
  8. Bruno E, et al. Cardiovascular findings, and clinical course, in patients with Williams syndrome: a 27-year experience from a single centre. Cardiol Young. 2003;13(3):273-282. PMID:12903797
  9. Zalzstein E, et al. Spectrum of cardiovascular lesions in supravalvular aortic stenosis: from familial to Williams-Beuren syndrome. Herz. 2003;28(8):673-679. PMID:14669038
  10. Kau T, et al. Supravalvular aortic stenosis: CT angiographic findings and surgical correlation. AJR Am J Roentgenol. 2009;193(4):W344-348. PMID:19770338